Service Experience
Print this page
Cardiology
Cardiology, Study No 3
- International, phase III, placebo-controlled study in patients with moderate risk of cardiovascular diseases
- Planned goal for KCR region: 1200 patients screened achieved in 4 months
- 45 active sites
- Competitive recruitment worldwide still ongoing
